CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI

    China SXT Pharmaceuticals, Inc. Announces Share

    TAIZHOU, China, Jan. 30, 2026 (GLOBE NEWSWIRE) — China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”),  a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today…

    Read More
    US SEC Chair Atkins vows to fast-track scrapping quarterly corporate reports, FT says

    US SEC Chair Atkins vows to fast-track scrapping quarterly corporate reports, FT says

    (Reuters) -U.S. Securities and Exchange Commission (SEC) Chairman Paul Atkins pledged to pursue minimal regulation and fast-track President Donald Trump‘s proposal to scrap quarterly earnings reports in an opinion piece for the Financial Times on Monday. “The government should provide the minimum effective dose of regulation needed to protect investors while allowing businesses to flourish,”…

    Read More
    Crypto ETFs set to flood US market as SEC streamlines approvals

    Crypto ETFs set to flood US market as SEC streamlines approvals

    (Reuters) — Asset managers are lining up to launch cryptocurrency exchange-traded funds, capitalizing on growing excitement around digital assets while getting a boost from looser regulatory requirements to bring products to market. The US Securities and Exchange Commission’s updated standards for ETFs, announced last week, could encourage demand for exchange-traded products tied to cryptocurrencies ranging…

    Read More
    SEC Halts Approval of Bitwise ETF

    SEC Halts Approval of Bitwise ETF

    A key US regulator halted the approval process for a new cryptocurrency exchange-traded fund just hours after initially signing off, in a setback for digital-asset proponents hoping for easy-to-trade funds that expand access to more tokens. Bloomberg’s Isabelle Lee reports. Source link

    Read More